Heart valve diseases, especially aortic stenosis (narrowing of the aortic valve), can severely affect a person’s quality of life. Patients may experience extreme fatigue, difficulty in breathing, chest pain, or even fainting spells. In severe cases, untreated aortic valve disease can lead to heart failure or sudden cardiac death. Traditionally, the only treatment option was open-heart valve replacement surgery, which involves large incisions, longer hospital stays, and prolonged recovery.
Transcatheter Aortic Valve Implantation (TAVI/TAVR) is a modern, minimally invasive procedure that offers a safer and quicker alternative to open surgery. Instead of opening the chest, a small catheter (a thin tube) is inserted through an artery in the groin or wrist and guided up to the heart. Through this catheter, a new artificial valve is delivered and carefully placed inside the diseased aortic valve. Once expanded, the new valve immediately takes over the function of regulating blood flow, allowing the heart to pump more effectively.
This procedure is especially useful for patients who are elderly, frail, or considered “high-risk” for open-heart surgery. It is also increasingly offered to younger patients who prefer less invasive options. Most patients notice a dramatic improvement in symptoms such as breathlessness, weakness, and dizziness within days of undergoing the procedure.
This procedure not only prolongs life but also enhances daily comfort, allowing patients to return to activities they enjoy. With modern imaging and advanced technology, TAVI is performed with a high degree of precision and safety. Patients often find themselves walking, eating, and resuming normal activities much faster than they ever expected.